Literature DB >> 27096756

Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14).

Selma Maacha1, Océane Anezo1, Malika Foy1, Géraldine Liot1, Laurence Mery1, Cécile Laurent2, Xavier Sastre-Garau3, Sophie Piperno-Neumann4, Nathalie Cassoux5, Nathalie Planque6, Simon Saule1.   

Abstract

PURPOSE: To study PTP4A3 phosphatase and MMP14 metalloprotease synergy in uveal melanoma aggressiveness.
METHODS: Cell membrane localization of matrix metalloprotease 14 (MMP14) in uveal melanoma cells expressing protein tyrosine phosphatase A3 (PTP4A3) was assessed by flow cytometry or immunohistochemistry. The vesicular trafficking of MMP14 in the presence of PTP4A3 was evaluated in OCM-1 cells expressing either the wild-type or mutated phosphatase. Finally, MMP14 localization at the cell membrane of OCM-1 cells was impaired using RNA interference, and the PTP4A3-related migration in vitro and invasiveness in vivo of the treated cells were evaluated.
RESULTS: We found that the membrane-anchored MMP14 is enriched at the cell surface of OCM-1 cells, patient-derived xenograft cells, and human primary uveal melanoma tumors expressing PTP4A3. Moreover, we show that PTP4A3 and MMP14 colocalize and that the vesicular trafficking of MMP14 is faster in the presence of active PTP4A3. Finally, we demonstrate that inhibition of MMP14 expression in uveal melanoma cells expressing PTP4A3 impairs their migration in vitro and invasiveness in vivo.
CONCLUSIONS: Our observations indicate that PTP4A3 increases cell membrane accumulation of MMP14 as a result of increased cellular trafficking of the metalloprotease. We also show that downregulation of MMP14 expression reduced PTP4A3-induced cell migration and invasiveness. Taken together, our findings suggest that PTP4A3-related subcellular localization of MMP14 is an important event in metastasis induction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27096756     DOI: 10.1167/iovs.15-18780

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.

Authors:  Miłosz Caban; Katarzyna Owczarek; Urszula Lewandowska
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  Epigenetic adaptations of the masticatory mucosa to periodontal inflammation.

Authors:  Gesa M Richter; Jochen Kruppa; H Gencay Keceli; Emel Tuğba Ataman-Duruel; Christian Graetz; Nicole Pischon; Gunar Wagner; Carsten Rendenbach; Yvonne Jockel-Schneider; Orlando Martins; Corinna Bruckmann; Ingmar Staufenbiel; Andre Franke; Rahime M Nohutcu; Søren Jepsen; Henrik Dommisch; Arne S Schaefer
Journal:  Clin Epigenetics       Date:  2021-11-03       Impact factor: 6.551

3.  Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.

Authors:  Mieszko Lachota; Anton Lennikov; Karl-Johan Malmberg; Radoslaw Zagozdzon
Journal:  J Immunol Res       Date:  2021-06-11       Impact factor: 4.818

4.  Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.

Authors:  Chaoju Gong; Jie Shen; Zejun Fang; Lei Qiao; Ruifang Feng; Xianmi Lin; Suyan Li
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

5.  Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma.

Authors:  Petros Tsantoulis; Mauro Delorenzi; Ivan Bièche; Sophie Vacher; Pascale Mariani; Nathalie Cassoux; Alexandre Houy; Marc-Henri Stern; Sergio Roman-Roman; Pierre-Yves Dietrich; Arnaud Roth; Wulfran Cacheux
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

6.  In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.

Authors:  Sekkarin Ploypetch; Sittiruk Roytrakul; Narumon Phaonakrop; Suthathip Kittisenachai; Kantinan Leetanasaksakul; Sirinun Pisamai; Chanin Kalpravidh; Anudep Rungsipipat; Gunnaporn Suriyaphol
Journal:  BMC Vet Res       Date:  2020-09-14       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.